Academic research project monitoring the effect of Autologous Hematopoietic Stem Cell Transplantation (AHSCT) on multiple sclerosis-associated lower urinary tract symptoms.
Subjects (male and female) aged 18 and over
Subjects with signed informed consent
Subjects able to undergo examination according to the protocol
Patients indicated by neurologists to perform AHSCT or treated with the closest similar disease-modifying therapy (control group)
Subjects with a history of bladder cancer
Subjects after previous pelvic radiotherapy
Subjects with evidence of microscopic or macroscopic hematuria
Subjects with a history of bladder reconstruction (augmentation cystoplasty, catheterizable stoma), subjects after cystectomy